بدائل البحث:
significant barriers » significant barrier (توسيع البحث), significant factors (توسيع البحث), significant burden (توسيع البحث)
barriers decrease » larger decrease (توسيع البحث), barrier disease (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
significant barriers » significant barrier (توسيع البحث), significant factors (توسيع البحث), significant burden (توسيع البحث)
barriers decrease » larger decrease (توسيع البحث), barrier disease (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
-
1
CKO mice display decreased skin barrier function and perturbed homeostasis.
منشور في 2025الموضوعات: -
2
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
3
-
4
-
5
-
6
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
منشور في 2024"…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…"
-
7
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
منشور في 2025"…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …"
-
8
-
9
-
10
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
منشور في 2025"…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …"
-
11
-
12
-
13
-
14
-
15
-
16
Altered expression of genes related to Ca<sup>2+</sup> cycling or myocardial contraction.
منشور في 2025الموضوعات: -
17
-
18
-
19
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …"
-
20